Bio-Rad Laboratories (BIO) Share-based Compensation Growth (1y) (2010 - 2025)
Bio-Rad Laboratories (BIO) Share-based Compensation Growth (1y) (2010 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn | 18.31% |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn | -78.13% |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn | 6.74% |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn | 16.00% |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | 12.53% |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn | -13.91% |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn | 60.71% |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 5.29% |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn | 7.56% |
| 10 | Bio-Rad Laboratories | 10.08 Bn | 8.46 Bn | 345.80 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 100.94% |
| Sep 30, 2025 | -257.69% |
| Dec 31, 2024 | -40.73% |
| Sep 30, 2024 | -65.17% |
| Dec 31, 2023 | -24,454.84% |
| Sep 30, 2023 | 438.69% |
| Dec 31, 2022 | 100.90% |
| Sep 30, 2022 | -137.05% |
| Jun 30, 2022 | 221.50% |
| Mar 31, 2022 | 15.38% |
| Dec 31, 2021 | 16.20% |
| Sep 30, 2021 | 230.49% |
| Jun 30, 2021 | -227.19% |
| Mar 31, 2021 | 20.62% |
| Dec 31, 2020 | -159.52% |
| Sep 30, 2020 | 162.14% |
| Jun 30, 2020 | 294.52% |
| Mar 31, 2020 | 14.12% |
| Dec 31, 2019 | 45.23% |
| Sep 30, 2019 | 227.24% |